本页面由Tiger Trade Technology Pte. Ltd.提供服务

Provectus生物制药

0.0617
-0.0001-0.10%
成交量:12.20万
成交额:7,529.14
市值:2,593.13万
市盈率:-4.65
高:0.0620
开:0.0617
低:0.0617
收:0.0618
52周最高:0.1050
52周最低:0.0380
股本:4.20亿
流通股本:3.87亿
量比:1.69
换手率:0.03%
股息:- -
股息率:- -
每股收益(TTM):-0.0133
每股收益(LYR):-0.0213
净资产收益率:22.69%
总资产收益率:-501.90%
市净率:-3.85
市盈率(LYR):-2.89

数据加载中...

2017/11/08

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2017/10/18

重要事件披露

8-K - Current report
2017/09/21

重要事件披露

8-K - Current report
2017/08/09

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2017/08/01

重要事件披露

8-K - Current report
2017/06/01

重要事件披露

8-K - Current report
2017/05/10

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2017/04/27

重要事件披露

8-K - Current report
2017/04/21

交易所摘牌声明

25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities
2017/04/21

交易所摘牌声明

25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities
2017/04/20

重要事件披露

8-K - Current report
2017/04/18

重要事件披露

8-K - Current report
2017/04/17

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2017/04/04

重要事件披露

8-K - Current report
2017/03/31

年度报告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2017/03/30

超过5%披露

SC 13D - General statement of acquisition of beneficial ownership
2017/03/30

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2017/03/30

重要事件披露

8-K - Current report
2017/03/23

重要事件披露

8-K - Current report
2017/03/21

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership